Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Sleep disorders and heart disease: Complicated relationship needs more research Erik Swain
-
- Javed Butler, MD: A nationally recognized HF investigator
- FDA approves expanded-indication study of TAVR valve
- FDA: Wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest
- Sutureless valve for surgical aortic valve replacement receives FDA approval
- New Dietary Guidelines set limit on added sugars, promote lifetime healthy eating patterns
- AHA: One in three US deaths caused by CVD
- AHA: Seven preventive measures may reduce HF risk
- Bioresorbable scaffold increases risk for stent thrombosis, MI vs. DES
-
- Congenital heart disease, neurodevelopmental delays linked to same genes
- Diabetes duration an important predictor of stroke in patients with AF
- ExcelsiorLOAD: Prasugrel superior to clopidogrel for platelet inhibition in stable patients undergoing PCI
- Familial hypercholesterolemia associated with high risk for aortic valve calcification
- Fragmented sleep in older adults may lead to severe cerebral arteriolosclerosis
- Fully magnetically levitated LV assist system shows positive outcomes in HF
- GRIPHON: Selexipag may reduce risk for death, complications in patients with pulmonary arterial hypertension
- Improvements in treatment yield decreases in all-cause, pulmonary embolism-related death
-
- Influenza vaccination rates vary widely in patients with HF
- Method to quantify late gadolinium enhancement helps predict outcomes of pulmonary vein isolation
- Multiple miscarriages may increase risk for CVD
- Nearly half of Americans who need cholesterol treatment not taking medication
- Novel antiplatelet agent shows promise in first-in-human study
- Novel transcarotid device yields low stroke rate during carotid artery stenting
- Perioperative statin therapy confers improved outcomes in patients after CABG
- Permanent AF may lead to cognitive impairment in patients with HF
-
- Review supports use of bioprosthetic aortic valves for middle-aged patients
- Safety, efficacy of sodium restriction in patients with HF questioned in new study
- SITAGRAMI: Progenitor cell therapy fails to show CV benefits
- Smoking affects life expectancy after acute MI
- Societies update performance measures for lipid management in secondary prevention
- Society updates listing criteria for heart transplantation
- Sugar-sweetened beverages associated with increased visceral fat
- Warning sign recognition may increase sudden cardiac arrest survival
-
- Weight control, aerobic fitness early in life may prevent hypertension in adulthood
- Women less likely to complete cardiac rehabilitation programs
- ACC launches new LAA closure registry
- CDC: After years of decline, US HF-related mortality rising again
- Use of pulmonary artery catheterization in patients with HF increased in recent years
- Risks to heart structure, function elevated in college football linemen
- Screening for Chagas’ disease in Latin American migrants identifies heart abnormalities, low mortality risk
- VIDEO: Athena Poppas, MD, reviews imaging modalities, underscores importance of integration
-
- VIDEO: Data on smoking cessation, diabetes therapies promising for CVD prevention
- VIDEO: Positive CV outcomes with SGLT2 inhibitors mark ‘an exciting time’
- Meeting Update: Experts offer insight on research unveiled at the annual AHA Scientific Sessions
- Trial Scorecard: BIOCRT
- Trial Scorecard: CHARON
- Trial Scorecard: CRIB-Donor
- Trial Scorecard: ExcelsiorLOAD
- Trial Scorecard: HART
-
- Trial Scorecard: LIPS2
- Trial Scorecard: RESCUE
- Trial Scorecard: SITAGRAMI